Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Unreal, another signing, millions added to the pot and there is - Head
5
Oct 04, 2007 06:23AM

I believe it all depends on two things.

One, how the first Schneider licensing agreement was written.  It may have (hopefully) been written with foresight, and specified products or product lines that are covered.  Introduction of a new product line, outside the scope of the original agreement, would require an additional license.

Two, though Schneider bought them out, they may retain them as a subsidiary (which is often done to retain name recognition).  Thus the products of that company would still be products of that company (not necessarily Schneider products), necessitating a license.

There may be more, but these two things immediately come to mind.  Also, these things may also come into play when other licensees do M or A activities.

So another new licensee.

Ex-cell-ent!

This I KNOW!

The PR still hasn't shown up in Yahoo Finance (i.e., the word isn't fully out yet).

SGE 

2
Oct 04, 2007 07:56AM

Oct 04, 2007 08:07AM
1
Oct 04, 2007 08:09AM
2
Oct 04, 2007 08:26AM

Oct 04, 2007 08:37AM
2
Oct 04, 2007 08:48AM
Share
New Message
Please login to post a reply